Science:华人科学家发现HIV新位点 推动疫苗进展

2016-05-14 张蔚然 中国新闻网

原题:美国科学家取得艾滋病毒研究重要进展 美国国家卫生研究院当地时间12日宣布,该院科学家针对艾滋病毒的研究取得重要进展,在艾滋病毒上发现了一个新的位点,该发现为艾滋疫苗的探索和研究打开了一条新的路径。 这一研究成果已于12日在美国《科学》杂志在线发表,论文的第一作者是美国国家卫生研究院过敏与传染病研究所下属疫苗研究中心的3位华人科学家,分别是孔瑞、许凯和周同庆,他们的研究方向包括抗体和疫苗

美国国家卫生研究院当地时间12日宣布,该院科学家针对艾滋病毒的研究取得重要进展,在艾滋病毒上发现了一个新的位点,该发现为艾滋疫苗的探索和研究打开了一条新的路径。

这一研究成果已于12日在美国《科学》杂志在线发表,论文的第一作者是美国国家卫生研究院过敏与传染病研究所下属疫苗研究中心的3位华人科学家,分别是孔瑞、许凯和周同庆,他们的研究方向包括抗体和疫苗、蛋白质结构和疫苗。

该研究院在声明中说,艾滋疫苗研究的策略之一是通过免疫方法诱导出能有效针对重要靶点的中和抗体,然而由于艾滋病毒的多变性,这样的靶点很有限。该院科学家们在艾滋病毒上发现了一个新的位点,这个位点可以被免疫系统产生的抗体分子识别,从而可以作为疫苗研究的新靶点,科学家也发现了这种抗体的作用机制。鉴于此,该发现为艾滋疫苗的探索和研究打开了一条新的路径。

据介绍,这项研究发现的新靶点在艾滋病毒膜蛋白上,由一段连续的8个氨基酸组成,是艾滋病毒融合肽的一部分。在此之前,艾滋病毒的融合肽没有被科学家视为疫苗设计的靶点。所以,此项发现的主要意义在于挖掘出艾滋病毒的一个“软肋”。以往的艾滋疫苗设计主要针对一些结构非常复杂的位点,设计难度很大,而融合肽的结构要简单很多,针对融合肽的疫苗设计有可能相对容易。

卫生研究院说,基于此项最新发现,该院科学家正集中精力设计新型疫苗,试图诱导出类似的融合肽抗体。

原始出处:

Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, Cale EM, Chen L, Choi CW, Chuang GY, Doria-Rose NA, Druz A, Georgiev IS, Gorman J, Huang J, Joyce MG, Louder MK, Ma X, McKee K, O'Dell S, Pancera M, Yang Y, Blanchard SC, Mothes W, Burton DR, Koff WC, Connors M, Ward AB, Kwong PD, Mascola JR. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. Science. 2016 May 13;352(6287):828-33. doi: 10.1126/science.aae0474.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
    2017-01-24 ylz8403
  3. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
    2016-05-16 jichang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
    2016-05-16 lovejing

    厉害啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
    2016-05-16 lovejing

    厉害啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
    2016-05-15 180****7709(上善若水)

    华人籍科学家 不是中国

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
    2016-05-15 medcardio

    最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1802318, encodeId=04fc180231826, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Apr 28 11:03:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018931, encodeId=5785201893147, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Tue Jan 24 10:03:00 CST 2017, time=2017-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375238, encodeId=b73c13e5238fa, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581911, encodeId=ffd41581911f9, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Mon May 16 13:03:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85971, encodeId=6cf0859e13d, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85972, encodeId=2031859e2f1, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon May 16 10:32:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85845, encodeId=d9ca8584591, content=华人籍科学家 不是中国, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1391689658, createdName=180****7709(上善若水), createdTime=Sun May 15 10:23:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85837, encodeId=e1d88583e0d, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85838, encodeId=9049858380a, content=最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sun May 15 10:03:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
    2016-05-15 medcardio

    最近来看,艾滋病的疫苗,研究进展非常迅速,有可能就在最近几年有,关键性突破,未来艾滋病不再是难题了。

    0

相关资讯

Nature子刊:天然植物岩蔷薇有望治疗艾滋病毒

在一项新的研究中,来自德国亥姆霍兹慕尼黑中心的研究人员发现药用植物白瑞木(Cistus incanus,也译作灰白岩蔷薇)的提取物阻止人免疫缺陷病毒(HIV)感染细胞。这种提取物中的抗病毒活性成分抑制HIV病毒蛋白停泊到细胞上。这种提取物中的抗病毒成分也具有抗埃博拉病毒和马尔堡病毒的作用。相关研究结果于2016年2月2日在线发表在Scientific Reports期刊上,论文标题为“Potent

盘点:世界上致命病毒排行榜

  图片来自:http://www.livescience.com/ 人类自诞生起,就一直在与病毒做斗争。对于现代人而异,某些病毒性疾病已经有了疫苗和抗病毒药物,使我们能够保持不被感染、阻碍其大肆传播,甚至还能在感染后被治好。在这场人类与病毒的斗争中,人类已经取得了阶段性的胜利,比如我们已经能彻底根除了天花病毒,数十年来再无新发案例。 但埃博拉疫情现在西非毁灭性的大传播表明,我

BMJ Open:中国浙江男男性行为群体中HIV感染率高达13.8%!

研究者在中国浙江进行了一项横断面研究,探究男男性行为者(MSM)中HIV患病率和危险行为,同时在该人群中抽样,开展未来可行的减少风险的干预措施。该研究共纳入1316名MSMS,以HIV发生率和危险因素为主要结局指标;同时收集参与者社会人口学和行为信息,以及梅毒患病率。校正后研究数据显示,该人群HIV和梅毒患病率分别为13.8%和11.4%。多因素分析显示更高的教育程度、HIV支持治疗、梅毒阴性是H

Lancet Infect Dis:全球目前有超过230万艾滋和丙肝的共感染患者

近日,一项来自布里斯托大学等机构的研究人员发现,目前全球大约有230万HIV感染者同时还是丙肝感染者(HCV),相关研究刊登于The Lancet Infectious Diseases杂志上。其中有超过一半患者(130万左右)都是注射吸毒者,本文研究发现,相比未感染HIV的个体而言,感染HIV的个体发生丙肝感染的可能性是前者的6倍,这就提示卫生组织个改善HIV/HCV共感染者的相应治疗政策。

这个年龄段男性性行为健康调查结果令人震惊!

一项对60-84岁的美国男性进行调查的新研究发表在 the American Journal of Men's Health上,研究结果表明:年龄越大,性行为越频繁,在商业性服务里体验无保护性行为的可能性就越大。作者Christine Milrod说:“目前普遍认为老年人不会花钱找性服务或者不会有规律的性行为。这种观点可能会给客户和性工作者带来错误的安全感,可能会导致更少的保护措施(与花钱体验性服

为何有些病毒那么热衷于通过精液传播?

为何有些病毒特别容易经精液传播本周,美国疾病控制和预防中心再次警告,Zika病毒可通过性传播。除此之外,男性患者病毒清除后仍可在其精液中存留数周。在此之前研究人员就已警告过病毒可在精液中存活很长的时间。埃博拉疫情爆发期间,研究人员发现,患者康复后病毒仍可在其精液中持续存在数月。有些病毒,如HIV,可通过精液有效传播,但是却不会通过其他的体液传播,如眼泪或尿液。这就提出了一个问题:精液有何特别之处?